Safety and Efficacy of Bimatoprost Ophthalmic Solution in Increasing Eyelash Prominence

This study will evaluate the safety and efficacy of bimatoprost ophthalmic solution 0.005% or 0.015% compared with bimatoprost ophthalmic solution 0.03% once-daily application to the upper eyelid margins in increasing eyelash prominence

Inclusion Criteria:

• Female Caucasians between 30 and 55 years of age, with hypotrichosis (inadequate or not enough) of the eyelashes
• Eyelash prominence assessment of minimal or moderate

Exclusion Criteria:

• Any eye disease or abnormality
• Any permanent eyeliner or eyelash implants of any kind
• Any ocular surgery, semi-permanent eyelash tint, or eyelash extension application during the 3 months prior to study entry
• Any use of prescription eyelash growth products
• Any use of over the counter eyelash growth products during the 6 months prior to baseline
• Any use of treatments that may affect hair growth during the 6 months prior to baseline